Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From mechanisms to clinical practice: a review of diuretic therapy in pediatric nephrology.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Single (375 mg/m<sup>2</sup>) vs. double dose of rituximab along with mycophenolate mofetil for children with steroid-dependent/frequently relapsing nephrotic syndrome: a multicentre open-label randomized controlled trial.

Pediatric nephrology (Berlin, Germany)·2024
Same author

Pollution status of microplastics in the sediments of warm monomictic Dal lake, India: Abundance, composition, and risk assessment.

Environmental pollution (Barking, Essex : 1987)·2024
Same author

Vitamin D and the Free Hormone Hypothesis.

Indian pediatrics·2024
Same author

An international, multi-center study evaluated rituximab therapy in childhood steroid-resistant nephrotic syndrome.

Kidney international·2024
Same author

Human exposure to uranium through drinking water and its detrimental impact on the human body organs.

Environmental geochemistry and health·2024
Same journal

Microbial Conversations Between the Gut and Urinary Tract: Emerging Implications for Kidney and Urinary Tract Diseases.

Indian pediatrics·2026
Same journal

Prevalence and Associated Social Factors of Prediabetes in Children and Adolescents in India: A Systematic Review and Meta-Analysis.

Indian pediatrics·2026
Same journal

Comparison of Early Intrapleural Fibrinolytic Therapy, Versus Administration After Failure of Intercostal Drainage in Children with Empyema Thoracis: A Systematic Review.

Indian pediatrics·2026
Same journal

Can Nebulized Epinephrine Prevent Extubation Failure in Neonates?

Indian pediatrics·2026
Same journal

Pragmatic Respiratory Stabilization During Neonatal Intubation-What Does this Trial Add for Indian NICUs?

Indian pediatrics·2026
Same journal

Universal Early-Life Screening in India: Time for a National Integrated Strategy.

Indian pediatrics·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2026

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

Published on: May 9, 2025

Hemolytic uremic syndrome.

Sushmita Banerjee1

  • 1Department of Pediatrics, Calcutta Medical Research Institute, Kolkata, India. asban@vsnl.com

Indian Pediatrics
|January 12, 2010
PubMed
Summary
This summary is machine-generated.

Hemolytic uremic syndrome (HUS) management focuses on supportive care, with rapid plasma therapy for infection-unrelated forms. Exact diagnosis and early treatment are crucial for improving outcomes in this severe condition.

More Related Videos

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
06:32

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions

Published on: June 13, 2025

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

Related Experiment Videos

Last Updated: Jun 17, 2026

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

Published on: May 9, 2025

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
06:32

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions

Published on: June 13, 2025

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

Area of Science:

  • Nephrology
  • Pediatrics
  • Internal Medicine

Background:

  • Hemolytic uremic syndrome (HUS) is a severe acute illness with potential long-term complications.
  • Diarrhea-unrelated HUS forms present a particularly poor prognosis.
  • Optimizing management and understanding etiology are key to improving patient outcomes.

Purpose of the Study:

  • To review current evidence on the etiology and management of Hemolytic uremic syndrome (HUS).
  • To explore strategies for optimizing patient outcomes in HUS.
  • To provide an updated perspective on HUS classification and diagnosis.

Main Methods:

  • Comprehensive literature search of major medical databases (Medline, Medscape, MDConsult, Cochrane) from 1998 onwards.
  • Systematic review of articles focusing on the etiopathogenesis and management of HUS.
  • Analysis of diagnostic advancements, including new assays and genetic studies.

Main Results:

  • HUS is now classified based on its specific cause.
  • Advanced diagnostic tools enable precise identification of atypical HUS forms.
  • Targeted therapies for atypical HUS, such as factor replacement, show promise.
  • Preventive strategies for diarrhea-associated HUS are still under investigation.

Conclusions:

  • Supportive care is fundamental for all HUS cases.
  • Prompt plasma therapy is indicated for infection-unrelated HUS.
  • Accurate etiological diagnosis is essential for guiding long-term treatment and prognosis.
  • Public health measures like improved sanitation and food hygiene are vital for preventing diarrhea-associated HUS.